… the QoL in patients with AGWs or cytological abnormalities. w14–w18 Patient preferences
with … interviews with 166 patients with genital warts, reports that most patients would have …

… patient-administered treatments reported in at least 1 parallel treatment group). Our analysis
covered a large number of patients … Our systematic review included RCTs of anogenital wart …

… Several therapeutic options are available to manage anogenital warts (AGWs). However,
no hierarchy of treatments is provided in the latest European and American recommendations. …

… -administered interventions for anogenital warts in immunocompetent patients: a systematic
… ) as an adjuvant treatment for anogenital warts was investigated. Similarities throughout the …

… of patients with anogenital warts by including evidence-based recommendations on diagnosis,
treatment, follow-up and advice to patients. … in the immunosuppressed or if left untreated. …

… Conventional therapy is not uniformly successful in the treatment of warts in the
immunocompromised patient, including HIV infected individuals, and immunotherapy is generally …

… in immunocompetent and immunosuppressed patients. … for the treatment of genital and
perianal warts, 5 and is now … for the treatment of genital and nongenital cutaneous warts and …

… of people with external genital and perianal warts and its efficacy in immunocompetent
patients has been assessed in several studies. Complete clearance of the warts occurred in 40% …

… increased the risk of intra-/perianal warts in renal transplant recipients. In conclusion, renal
transplant recipients in this study had higher odds of external anogenital warts than controls. …

… to 39 RCTs, included immunocompromised patients and only one RCT using CO 2 laser [64],
whereas our NMA compared 49 RCTs, focused on non-immunocompromised adults and …